Agios Pharmaceuticals Reports Third Quarter 2013 Financial Results Read more about Agios Pharmaceuticals Reports Third Quarter 2013 Financial Results
Agios Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on November 7, 2013 Read more about Agios Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on November 7, 2013
Agios to Present IDH Program Insights at AACR-NCI-EORTC International Conference Read more about Agios to Present IDH Program Insights at AACR-NCI-EORTC International Conference
Agios Pharmaceuticals Added to Russell 2000®, 3000® and Global Indexes Read more about Agios Pharmaceuticals Added to Russell 2000®, 3000® and Global Indexes
Agios Pharmaceuticals Appoints Paul J. Clancy to Its Board of Directors Read more about Agios Pharmaceuticals Appoints Paul J. Clancy to Its Board of Directors
Agios Pharmaceuticals Enrolls First Patient in Phase 1 Study of AG-221 in Advanced Hematologic Malignancies with an IDH2 Mutation Read more about Agios Pharmaceuticals Enrolls First Patient in Phase 1 Study of AG-221 in Advanced Hematologic Malignancies with an IDH2 Mutation
Agios Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference Read more about Agios Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
Agios Pharmaceuticals to Present New Research at the 12th International Congress of Inborn Errors of Metabolism Read more about Agios Pharmaceuticals to Present New Research at the 12th International Congress of Inborn Errors of Metabolism
Agios Pharmaceuticals Named 2014 World Economic Forum Technology Pioneer Read more about Agios Pharmaceuticals Named 2014 World Economic Forum Technology Pioneer
Agios Pharmaceuticals Closes Initial Public Offering Read more about Agios Pharmaceuticals Closes Initial Public Offering